Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

First Wave Biopharma Inc (FWBI)

First Wave Biopharma Inc (FWBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

First Wave Biopharma Inc 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 USA

www.firstwavebio.com P: 561-589-7020

Description:

First Wave BioPharma Inc. is a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal diseases. First Wave BioPharma Inc., formerly known as AzurRx BioPharma Inc., is based in BOCA RATON, Fla.

Key Statistics

Overview:

Market Capitalization, $K 7,326
Enterprise Value, $K 3,616
Shares Outstanding, K 2,475
Annual Sales, $ 0 K
Annual Net Income, $ -15,790 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -4,100 K
EBIT, $ -15,760 K
EBITDA, $ -15,730 K
60-Month Beta 1.28
% of Insider Shareholders 0.49%
% of Institutional Shareholders 12.30%
Float, K 2,463
% Float 99.51%
Short Volume Ratio 0.51

Growth:

1-Year Return -94.39%
3-Year Return -99.99%
5-Year Return -100.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 99.87%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.38 on 05/14/24
Next Earnings Date 05/17/24
Earnings Per Share ttm -83.40
EPS Growth vs. Prev Year 101.04%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 12/18/23

FWBI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -102.83%
Return-on-Assets % -22.74%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.37
Book Value/Share 2.31
Interest Coverage -788.50
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar